Showing results (81-90 of 382) with videos related to

Sort By:
Pageof 39
Annals of Hematology|May 22, 2015
Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemiaTanja Schneider, Anne Flörcken, Anju Singh, et al.
Journal of Internal Medicine|May 22, 2022
Application of precision medicine in clinical routine in haematology-Challenges and opportunitiesTove Wästerlid, Lucia Cavelier, Claudia Haferlach, et al.
Cancers|March 14, 2020
Functional Classification of TP53 Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Haematologica|December 18, 2009
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrationsFrank Stegelmann, Lars Bullinger, Martin Griesshammer, et al.
Blood Advances|June 25, 2026
Rapid and Reproducible Karyotyping with Long Read Sequencing in AML PatientsMichael Heuser, Anna Dolnik, Isabell Arnhardt, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Experimental Hematology|November 12, 2013
Transitory dasatinib-resistant states in KIT(mut) t(8;21) acute myeloid leukemia cells correlate with altered KIT expressionMarkus D Herrmann, Jochen K Lennerz, Lars Bullinger, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|May 5, 2020
Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's DiseasePascal Schlosser, Jochen Knaus, Maximilian Schmutz, et al.
Oncotarget|December 30, 2016
Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cellsArefeh Rouhi, Christina Miller, Sarah Grasedieck, et al.
Blood|July 30, 2005
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsKonstanze Döhner, Richard F Schlenk, Marianne Habdank, et al.
Pageof 39